Montelukast in Chronic Asthma

Completed

• Conditions: Asthma

• Registration Number: NCT00802789
• Lead Sponsor: Organon and Co

Brief Summary

Treatment of patients insufficiently treated with ICS or ICS + LABA.

Detailed Description

Not available

Study Timeline

• Study Start: 2007-04
• Primary Completion: 2008-09
• Study Completion: 2008-10
• Study First Submitted: 2008-12-04
• Study First Submitted QC: 2008-12-04
• Study First Posted: 2008-12-05
• Status Verified: 2022-02
• Last Update Submitted: 2022-02-07
• Last Update Posted: 2022-02-18

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 2000

Inclusion Criteria

• Patients Insufficiently Treated With ICS Or ICS + LABA.

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Documentation of asthma control via ACT (Asthma Control Test).	6 months (12 months optional)

Secondary Outcome Measures

Name	Time	Method
Mini Asthma Quality of Life Questionnaire (Mini AQLQ).	6 months (12 months optional)